Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion Pharmaceuticals RXRX, a TechBio company that decodes biology and chemistry to industrialize drug discovery, is expected to report fourth-quarter 2025 results soon. The Zacks Consensus ...

Marianne Bonner, CPCU, ARM, covers business insurance topics for Investopedia, building on 30 years of experience working in the insurance industry. She has written extensively for The Risk Report, ...

A developer’s routine cleanup task reportedly turned into a disaster after a small mistake in AI-generated code wiped an entire drive. The incident, first described in a Reddit post, involved code ...

Explaining the policies and processes that define our journalism. “The Times’s primary responsibility is to give readers accurate information, and our readers trust us to do that. By acknowledging our ...

点击上方“Deephub Imba”,关注公众号,好文章不错过 !用语言模型写代码、查数据库、跑自动化流程这些事情大家早就习以为常了。Vibe Coding ...